2型糖尿病患者体重波动与心血管结局及死亡风险:减重干预背景下的分析
该研究为Look AHEAD试验的前瞻性队列分析,纳入基线无心血管疾病的2型糖尿病成人3604例,来自美国16个中心,随访中位6.7年。以4次年度访视的体重指数和腰围变异(变异系数、独立于均值的变异、标准差)为暴露,评估其与全因死亡、心血管死亡及心血管事件的关联。对照组中,体重指数变异系数最高四分位(Q4)相比最低四分位(Q1)的全因死亡HR为4.06(95%CI 2.17-7.57),心血管死亡HR为15.28(95%CI 2.89-80.90),心血管事件HR为2.16(95%CI 1.21-3.87);干预组相应HR分别为0.99(95%CI 0.45-2.16)、1.14(95%CI 0.12-10.53)、0.77(95%CI 0.40-1.49)。腰围变异在对照组中Q4 vs Q1的全因死亡HR为1.84(95%CI 1.01-3.35),心血管死亡HR为6.46(95%CI 1.16-36.01),心血管事件HR为1.28(95%CI 0.72-2.29)。作者认为,在强化生活方式干预背景下,体重指数变异与不良结局的关联可能被削弱。
要点
- 在对照组中,体重指数变异系数Q4 vs Q1的全因死亡HR为4.06(95%CI 2.17-7.57),心血管死亡HR为15.28(95%CI 2.89-80.90),心血管事件HR为2.16(95%CI 1.21-3.87)。
- 在强化生活方式干预组中,体重指数变异系数Q4 vs Q1的全因死亡HR为0.99(95%CI 0.45-2.16),心血管死亡HR为1.14(95%CI 0.12-10.53),心血管事件HR为0.77(95%CI 0.40-1.49)。
- 对照组中腰围变异Q4 vs Q1的全因死亡HR为1.84(95%CI 1.01-3.35),心血管死亡HR为6.46(95%CI 1.16-36.01),心血管事件HR为1.28(95%CI 0.72-2.29)。
- 干预组中腰围变异Q4 vs Q1的全因死亡HR为1.23(95%CI 0.61-2.46),心血管死亡HR为0.55(95%CI 0.15-2.11),心血管事件HR为0.70(95%CI 0.39-1.25)。
- 中位随访6.7年间,共发生216例心血管事件、33例心血管死亡和166例死亡。
适用人群与场景
- Look AHEAD试验参与者,基线无心血管疾病的2型糖尿病成人,来自美国16个中心。
- 纳入时间2001年8月至2004年4月,共3604例;平均(标准差)年龄58.4(6.6)岁,女性2240例(62.3%),黑人1364例(37.7%),白人2404例(66%)。
研究设计与关键结果
- 研究设计:前瞻性队列研究,纳入Look AHEAD试验中基线无心血管疾病的2型糖尿病成人3604例,来自美国16个中心。
- 暴露:4次年度访视的体重指数和腰围变异,采用变异系数、独立于均值的变异和标准差评估。
- 主要结局:全因死亡、心血管死亡(心肌梗死或卒中死亡)、心血管事件(心肌梗死、卒中或心血管原因死亡)。
- 中位随访6.7年,共发生216例心血管事件、33例心血管死亡和166例死亡。
- 对照组中,体重指数变异系数Q4 vs Q1的全因死亡HR为4.06(95%CI 2.17-7.57),心血管死亡HR为15.28(95%CI 2.89-80.90),心血管事件HR为2.16(95%CI 1.21-3.87)。
- 干预组中,体重指数变异系数Q4 vs Q1的全因死亡HR为0.99(95%CI 0.45-2.16),心血管死亡HR为1.14(95%CI 0.12-10.53),心血管事件HR为0.77(95%CI 0.40-1.49)。
- 对照组中,腰围变异Q4 vs Q1的全因死亡HR为1.84(95%CI 1.01-3.35),心血管死亡HR为6.46(95%CI 1.16-36.01),心血管事件HR为1.28(95%CI 0.72-2.29)。
- 干预组中,腰围变异Q4 vs Q1的全因死亡HR为1.23(95%CI 0.61-2.46),心血管死亡HR为0.55(95%CI 0.15-2.11),心血管事件HR为0.70(95%CI 0.39-1.25)。
证据类型、等级与局限
- 证据类型:前瞻性队列研究(基于Look AHEAD试验)。
- 作者结论:在2型糖尿病患者中,较高的肥胖指标变异在对照组与心血管结局和死亡风险显著增加相关,但在强化生活方式干预组未见此关联。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论提示,在2型糖尿病患者中,较高的体重指数和腰围变异在对照组与心血管结局和死亡风险显著增加相关,但在强化生活方式干预组未见此关联。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Body weight fluctuation is associated with greater risks of adverse health outcomes. Whether intensive weight loss interventions affect the association of variability in adiposity measures with adverse health outcomes in individuals with type 2 diabetes has not been studied previously.
OBJECTIVE: To evaluate the associations of long-term variability in adiposity indices with cardiovascular disease (CVD) outcomes and whether these associations are affected by an intensive lifestyle intervention among adults with type 2 diabetes.
DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study included participants in the Action for Health in Diabetes (Look AHEAD) trial without CVD at baseline (August 2001 to April 2004). The Look AHEAD study included 16 centers in the United States. Data analysis was performed from December 2020 to June 2021.
EXPOSURES: Variability of body mass index (BMI) and waist circumference (WC) across 4 annual visits, assessed using the coefficient of variation (CV), variability independent of the mean (VIM), and standard deviation (SD).
MAIN OUTCOMES AND MEASURES: Main outcomes were (1) all-cause mortality, (2) cardiovascular deaths (deaths from myocardial infarction [MI] or stroke), and (3) CVD events (MI, stroke, and/or death from cardiovascular causes).
RESULTS: Among 3604 study participants (mean [SD] age, 58.4 [6.6] years; 2240 [62.3%] women; 1364 [37.7%] Black participants; 2404 [66%] White participants), there were 216 CVD events, 33 CVD deaths, and 166 deaths over a median of 6.7 years. In the control group, the hazard ratios (HRs) for the highest quartile (quartile 4) compared with the lowest quartile (quartile 1) of CV of BMI were 4.06 (95% CI, 2.17-7.57), 15.28 (95% CI, 2.89-80.90), and 2.16 (95% CI, 1.21-3.87) for all-cause mortality, CVD mortality, and cardiovascular events, respectively. In the intervention group, the corresponding HRs were 0.99 (95% CI, 0.45-2.16), 1.14 (95% CI, 0.12-10.53), and 0.77 (95% CI, 0.40-1.49) for quartile 4 vs quartile 1. Regarding WC, in the control group, HRs for quartile 4 vs quartile 1 were 1.84 (95% CI, 1.01-3.35), 6.46 (95% CI, 1.16-36.01), and 1.28 (95% CI, 0.72-2.29). In the intervention group, HRs were 1.23 (95% CI, 0.61-2.46), 0.55 (95% CI, 0.15-2.11), and 0.70 (95% CI, 0.39-1.25) for quartile 4 vs quartile 1.
CONCLUSIONS AND RELEVANCE: In this cohort study of individuals with type 2 diabetes, higher variability of adiposity indices was associated with significantly increased risk of CVD outcomes and death in the control group but not in the intensive lifestyle intervention group.
参考来源
- Kaze AD, Santhanam P, Erqou S, et al. Body Weight Variability and Risk of Cardiovascular Outcomes and Death in the Context of Weight Loss Intervention Among Patients With Type 2 Diabetes. JAMA Netw Open. 2022. PMID: 35179583. doi:10.1001/jamanetworkopen.2022.0055
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。